Furiex Pharmaceuticals, Inc. 4
4 · Furiex Pharmaceuticals, Inc. · Filed Mar 4, 2014
Insider Transaction Report
Form 4
COVINGTON PAUL S
Senior VP-Clinical Operations
Transactions
- Award
Common Stock
2014-02-28+13,500→ 28,623 total
Holdings
- 10,368
Stock Options (to buy)
Exercise: $17.80Exp: 2022-02-24→ Common Stock (10,368 underlying) - 45,691
Stock Options (to buy)
Exercise: $9.11Exp: 2020-06-17→ Common Stock (45,691 underlying) - 26,000
Stock Options (to buy)
Exercise: $15.00Exp: 2021-05-09→ Common Stock (26,000 underlying) - 37,944
Stock Options (to buy)
Exercise: $13.16Exp: 2021-10-03→ Common Stock (37,944 underlying)
Footnotes (5)
- [F1]Represents a restricted stock award which vests annually in two equal installments on February 28, 2015 and 2016, subject to continued employment.
- [F2]The options were awarded on 6/17/2010 and vest over three years, with one-third vesting on each of the first, second and third anniversaries of the date of grant, provided the Optionee's employment continues.
- [F3]The options were awarded on 5/9/2011. One-third of the options vest on the date of grant and the remaining two-thirds vest in two equal annual installments on the first and second anniversaries of the date of grant, provided the Optionee's employment continues.
- [F4]The options were awarded on 10/3/2011 and vest over three years, with one-third vesting on each of the first, second and third anniversaries of the date of grant, provided the Optionee's employment continues.
- [F5]The options were awarded on 2/24/2012 and vest over three years, with one-third vesting on each of the first, second and third anniversaries of the date of grant, provided the Optionee's employment continues.